Eisai gets go ahead for Alzheimer’s appeal
December 10, 2007Alzheimer's, Eisai, NICE
Eisai is to make one more legal challenge to NICE by taking its case on Alzheimer’s drugs to the Court …
ABPI names new president
December 10, 2007ABPI
AstraZeneca's Chris Brinsmead has been named as the next president of the ABPI.He will take over from the current ABPI …
Latest news from Datamonitor
December 10, 2007Research and Development
Adventrx completes enrolment for breast cancer trialAdventrx Pharmaceuticals has completed patient enrolment in its Phase II clinical trial of CoFactor …
Safety first
December 10, 2007Research and Development, Sales and Marketing clinical trials, drug development, drug safety
There is a tide of change in drug safety within the pharmaceutical industry. Internal and external forces are pushing drug …
NICE approves Novartis asthma jab
November 30, 2007Sales and Marketing
NICE has recommended Novartis' injection Xolair for asthma patients whose condition cannot be controlled by conventional first-line treatments. Patients with …
New GP practices for deprived areas
November 30, 2007Health secretary Alan Johnson has unveiled plans to open 100 new practices in under-doctored areas within the next three years. …
Ezetrol receives NICE approval
November 30, 2007Sales and Marketing
NICE has approved Ezetrol, the cholesterol-lowering drug marketed by MSD and Schering-Plough. Data shows the drug significantly reduces bad cholesterol …
Divert money from Herceptin, says radiotherapy leader
November 30, 2007Sales and Marketing
Money currently being spent on Herceptin for breast cancer patients could be better spent on providing radiotherapy, a leader in …
Sanofi and Regeneron sign antibody deal
November 30, 2007Research and Development
Sanofi-Aventis has increased its stake in Regeneron and will collaborate with the US biotech company on new antibody research.The companies …
Short sighted pharma undermining its own future, says Oxfam
November 30, 2007Sales and Marketing
Pharmaceutical companies are damaging their businesses by blocking access to drugs for millions of people in the developing world, according …
Wyeth kidney cancer drug approved in Europe
November 29, 2007Sales and Marketing
Wyeth's orphan cancer drug Torisel has been approved in Europe for difficult to treat cases of advanced renal cell carcinoma.It …
European approval for Merck’s cyanide antidote
November 29, 2007Sales and Marketing
European regulators have approved Merck Serono's cyanide poisoning cure Cyanokit for use in adults and children. Cyanide poisoning is primarily …
Latest news from Datamonitor
November 29, 2007Research and Development
Medivir to initiate Phase IIa study of hepatitis CMedivir has announced that a Phase IIa study for its investigational hepatitis …
Do regional marketing teams really work?
November 29, 2007Sales and Marketing Europe, marketing, regional marketing
In this feature, we tackle the subject of the regional marketing team and look at a number of issues, including …
The new prescriber: friend or foe?
November 22, 2007Sales and Marketing nursing, pharma, pharmacy, sales
Champix linked to depression and suicidal thoughts
November 22, 2007Sales and Marketing reg, safety
Pfizer has alerted US regulator the FDA to cases of depression and suicidal thoughts in patients taking its smoking cessation …
Pfizer buys immune system specialists Coley
November 22, 2007Research and Development
Pfizer is to acquire a company developing new drugs that fight diseases by altering the immune system. The company is …
NHS set for major underspend
November 22, 2007Efforts to save money in the NHS have proved so successful that the health service is set to underspend its …
Ethical dilemma for doctors must be confronted, says bowel cancer charity
November 22, 2007Many bowel cancer patients are not being informed of all treatment options because their doctors feel embarrassed about having a …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
